clioquinol has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies
Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L | 1 |
| Fan, Y | 1 |
| Zhang, X | 1 |
| Yang, L | 1 |
| Huang, W | 1 |
| Hang, T | 1 |
| Li, M | 1 |
| Du, S | 1 |
| Ma, J | 1 |
1 other study available for clioquinol and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
Zinc supplementation inhibits the high glucose‑induced EMT of peritoneal mesothelial cells by activating the Nrf2 antioxidant pathway.
Topics: Animals; Cadherins; Clioquinol; Dietary Supplements; Epithelial-Mesenchymal Transition; Epithelium; | 2019 |